Gisela Canals-Esquerda
Barcelona, CT 08193, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Cognitive Impairment in the 3xTg-AD Mouse Model of Alzheimer's Disease is Affected by Aβ-ImmunoTherapy and Cognitive Stimulation.
Journal: Pharmaceutics
Published: August 11, 2020
Progression of Alzheimer's disease and effect of scFv-h3D6 immunotherapy in the 3xTg-AD mouse model: An in vivo longitudinal study using Magnetic Resonance Imaging and Spectroscopy.
Journal: NMR in biomedicine
Published: July 31, 2019
Treatment with scFv-h3D6 Prevented Neuronal Loss and Improved Spatial Memory in Young 3xTg-AD Mice by Reducing the Intracellular Amyloid-β Burden.
Journal: Journal of Alzheimer's disease : JAD
Published: July 16, 2019
Differential effects of apoE and apoJ mimetic peptides on the action of an anti-Aβ scFv in 3xTg-AD mice.
Journal: Biochemical pharmacology
Published: May 08, 2018
An Intracellular Amyloid-β/AβPP Epitope Correlates with Neurodegeneration in those Neuronal Populations Early Involved in Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: July 13, 2017
Mouse Models of Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: March 18, 2017
Aβ immunotherapy for Alzheimer's disease: where are we?
Journal: Neurodegenerative disease management
Published: May 28, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026